1. Home
  2. WLKP vs STOK Comparison

WLKP vs STOK Comparison

Compare WLKP & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLKP
  • STOK
  • Stock Information
  • Founded
  • WLKP 2014
  • STOK 2014
  • Country
  • WLKP United States
  • STOK United States
  • Employees
  • WLKP N/A
  • STOK N/A
  • Industry
  • WLKP Major Chemicals
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • WLKP Industrials
  • STOK Health Care
  • Exchange
  • WLKP Nasdaq
  • STOK Nasdaq
  • Market Cap
  • WLKP 833.7M
  • STOK 638.8M
  • IPO Year
  • WLKP 2014
  • STOK 2019
  • Fundamental
  • Price
  • WLKP $22.46
  • STOK $11.48
  • Analyst Decision
  • WLKP
  • STOK Strong Buy
  • Analyst Count
  • WLKP 0
  • STOK 5
  • Target Price
  • WLKP N/A
  • STOK $24.50
  • AVG Volume (30 Days)
  • WLKP 31.9K
  • STOK 530.1K
  • Earning Date
  • WLKP 08-05-2025
  • STOK 08-06-2025
  • Dividend Yield
  • WLKP 8.40%
  • STOK N/A
  • EPS Growth
  • WLKP N/A
  • STOK N/A
  • EPS
  • WLKP 1.49
  • STOK 0.88
  • Revenue
  • WLKP $1,088,852,000.00
  • STOK $190,908,000.00
  • Revenue This Year
  • WLKP $8.90
  • STOK $378.84
  • Revenue Next Year
  • WLKP $6.87
  • STOK N/A
  • P/E Ratio
  • WLKP $15.07
  • STOK $13.09
  • Revenue Growth
  • WLKP N/A
  • STOK 2333.81
  • 52 Week Low
  • WLKP $21.19
  • STOK $5.35
  • 52 Week High
  • WLKP $25.04
  • STOK $16.15
  • Technical
  • Relative Strength Index (RSI)
  • WLKP 50.63
  • STOK 58.05
  • Support Level
  • WLKP $21.96
  • STOK $11.19
  • Resistance Level
  • WLKP $22.45
  • STOK $12.00
  • Average True Range (ATR)
  • WLKP 0.28
  • STOK 0.53
  • MACD
  • WLKP 0.06
  • STOK -0.10
  • Stochastic Oscillator
  • WLKP 70.49
  • STOK 28.70

About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests

Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: